Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment

被引：0

作者：

Graf, Christiana ^{[1
]}

Degasperi, Elisabetta ^{[2
]}

D'Ambrosio, Roberta ^{[2
]}

Llaneras, Jordi ^{[3
]}

Vermehren, Johannes ^{[1
]}

Dultz, Georg ^{[1
]}

Wetzstein, Nils ^{[4
]}

Herrmann, Eva ^{[5
]}

Zeuzem, Stefan ^{[1
]}

Buti, Maria

Lampertico, Pietro

Dietz, Julia ^{[1
]}

Sarrazin, Christoph ^{[1
,6
]}

机构：

[1] Univ Hosp Frankfurt, Dept Internal Med, Frankfurt, Germany

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[3] UAB Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Med, Barcelona, Spain

[4] Univ Hosp Frankfurt, Dept Internal Med Infect Dis, Frankfurt, Germany

[5] Goethe Univ Frankfurt, Inst Biostatist & Math Modeling, Frankfurt, Germany

[6] St Josefs Hosp, Med Klin II, Wiesbaden, Germany

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-129-YI

引用

页码：S98 / S99

页数：2

共 50 条

[1] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Graf, Christiana
D'Ambrosio, Roberta
Degasperi, Elisabetta
Paolucci, Stefania
Llaneras, Jordi
Vermehren, Johannes
Dultz, Georg
Peiffer, Kai-Henrik
Finkelmeier, Fabian
Herrmann, Eva
Zeuzem, Stefan
Buti, Maria
Lampertico, Pietro
Dietz, Julia
Sarrazin, Christoph
JHEP REPORTS, 2024, 6 (03)
[2] REAL-WORLD EFFECTIVENESS OF VOXILAPREVIR/VELPATASVIR/SOFOSBUVIR IN DAA FAILURE PATIENTS: AN INTEGRATIVE ANALYSIS
Graf, Christiana
D'Ambrosio, Roberta
Degasperi, Elisabetta
Paolucci, Stefania
Llaneras, Jordi
Vermehren, Johannes
Dultz, Georg
Peiffer, Kai-Henrik
Herrmann, Eva
Zeuzem, Stefan
Buti, Maria
Lampertico, Pietro
Dietz, Julia
Sarrazin, Christoph
HEPATOLOGY, 2023, 78 : S739 - S739
[3] Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure
Degasperi, Elisabetta
Spinetti, Angiola
Lombardi, Andrea
Landonio, Simona
Rossi, Maria Cristina
Pasulo, Luisa
Pozzoni, Pietro
Giorgini, Alessia
Fabris, Paolo
Romano, Antonietta
Lomonaco, Lorenzo
Puoti, Massimo
Vinci, Maria
Gatti, Federico
Carolo, Giada
Zoncada, Alessia
Bonfanti, Paolo
Russo, Francesco Paolo
Aghemo, Alessio
Soria, Alessandro
Centenaro, Riccardo
Maggiolo, Franco
Rovere, Pierangelo
Pasin, Francesca
Paon, Veronica
Faggiano, Giovanni
Vario, Alessandro
Grossi, Glenda
Soffredini, Roberta
Carriero, Canio
Paolucci, Stefania
Noventa, Franco
Alberti, Alfredo
Lampertico, Pietro
Fagiuoli, Stefano
D'Ambrosio, Roberta
Degasperi, Elisabetta
Borghi, Marta
Perbellini, Riccardo
Gori, Andrea
Ferroni, Valentina
Pasulo, Luisa
Manini, Maria Colpani Matteo
Cologni, Giuliana
Lazzaroni, Sergio
Del Poggio, Paolo
Vinci, Maria
De Nicola, Stella
Mazzarelli, Chiara
Zucchetti, Teresa Angelini
JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1106 - 1115
[4] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
Janjua, Naveed
Wilton, James
Cook, Darrel
Wong, Stanley
Butt, Zahid
Bartlett, Sofia
Pearce, Margo
Ramji, Alnoor
Yoshida, Eric
Yu, Amanda
Alvarez, Maria
Binka, Mawuena
Krajden, Mel
JOURNAL OF HEPATOLOGY, 2020, 73 : S356 - S357
[5] REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT
Krajden, Mel
Cook, Darrel
Wong, Stanley
Wilton, James
Butt, Zahid Ahmad
Bartlett, Sofia
Pearce, Margo
Ramji, Alnoor
Yoshida, Eric M.
Yu, Amanda
Alvarez, Maria Jose
Binka, Mawuena
Janjua, Naveed
HEPATOLOGY, 2019, 70 : 914A - 914A
[6] Real-World Safety and Effectiveness of Sofosbuvir/Velpatasvir/Voxilaprevir and Glecaprevir/Pibrentasvir in Hepatitis C Infected Patients
Saxena, Varun
Chamberland, Scott
Hurley, Leo
Lai, Jennifer B.
Truong, Elizabeth
Marcus, Julia
Champsi, Jamila
Hare, Brad B.
Korn, Daniel
Ready, Joanna B.
Seo, Suk
Witt, David J.
Silverberg, Michael J.
HEPATOLOGY, 2018, 68 : 418A - 419A
[7] REAL-LIFE EFFECTIVENESS AND SAFETY OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR FOR CHRONIC HEPATITIS C PATIENTS WITH PRIOR DAA FAILURE: FINAL RESULTS OF THE NAVIGATORE NETWORK
Degasperi, Elisabetta
Spinetti, Angiola
Lombardi, Andrea
Landonio, Simona
Rossi, Cristina
Pasulo, Luisa
Pozzoni, Pietro
Giorgini, Alessia
Fabris, Paolo
Romano, Antonietta
Lomonaco, Lorenzo
Puoti, Massimo
Vinci, Maria
Gatti, Federico
Carolo, Giada
Zoncada, Alessia
Bonfanti, Paolo
Russo, Francesco Paolo
Aghemo, Alessio
Soria, Alessandro
Centenaro, Riccardo
Maggiolo, Franco
Rovere, Pierangelo
Pasin, Francesca
Paon, Veronica
Faggiano, Giovanni
Vario, Alessandro
Grossi, Glenda
Soffredini, Roberta
Carriero, Canio
Paolucci, Stefania
Noventa, Franco
Alberti, Alfredo
Lampertico, Pietro
Fagiuoli, Stefano
HEPATOLOGY, 2019, 70 : 987A - 988A
[8] Real-Life Effectiveness and Safety of Velpatasvir/Sofosbuvir/Voxilaprevir for Previously Daa Treated Patients with Chronic Hepatitis C
Llaneras, Jordi
Riveiro Barciela, Mar
Lens, Sabela
Baliellas, Carme
Diago, Moises
Javier Garcia-Samaniego, Francisco
Arencibia, Ana C.
Arenas, Juan
Conde, Isabel
Gea, Francisco
Torras Collell, Xavier
Luis Calleja, Jose
Antonio Carrion, Jose
Fernandez, Inmaculada
Morillas, Rosa
Rosales Zabal, Jose Miguel
Carmona, Isabel
Fernandez-Rodriguez, Conrado M.
Hernandez Guerra, Manuel Nicolas
Llerena, Susana
Bernal, Vanesa
Turnes, Juan
Manuel Gonzalez, Jesus
Montoliu, Silvia
Figueruela, Blanca
Badia, Ester
Delgado, Manuel
Fernandez, Miguel
Inarrairaegui, Mercedes
Manuel Pascasio, Juan
Rodriguez-Frias, Francisco
Esteban, Rafael
Buti, Maria
HEPATOLOGY, 2018, 68 : 405A - 406A
[9] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients
Belperio, Pamela S.
Shahoumian, Troy A.
Loomis, Timothy P.
Backus, Lisa I.
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) : 980 - 990
[10] Real-World Effectiveness of Sofosbuvir/Velpatasvir/Voxilaprevir in 573 Treatment-Experienced Patients with Hepatitis C Genotypes 1 through 4
Belperio, Pamela S.
Shahoumian, Troy
Loomis, Timothy
Mole, Larry
Backus, Lisa I.
HEPATOLOGY, 2018, 68 : 142A - 142A

← 1 2 3 4 5 →